Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Multi-omics feature engineering driven by biomedical foundation models improves drug response prediction for inflammatory bowel disease patients.
PMID 41844950 · PMC13129071 · Scientific reports · 2026 · 8 claims · 7 setups
FM (MAMMAL)-derived drug-target binding affinity (BA) inference can be used to rank/select biologically relevant protein targets and their associated genes/SNPs for a drug of interest without knowledge of protein structure or active sites
-
Full-text index only
Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease.
PMID 41794040 · PMC13006398 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
CSF exhibits distinct, disease-specific immune landscapes across CNSL, BrMs, and GB-associated LMD
-
Full-text index only
Nuclear Myosin 1 links genomic architecture to adipose tissue remodeling, metabolic inflammation and obesity in mice.
PMID 41748556 · PMC13004839 · Cell death & disease · 2026 · 8 claims · 8 setups
NM1 is required for metabolic homeostasis during adipocyte differentiation
-
Full-text index only
Highlights of international conference of immunogenomics and immunomics, October 8-12, 2006 Budapest, Hungary.
PMID 17470366 · PMC7130317 · Cellular immunology · 2006 · 8 claims · 8 setups
An 'immunological constant of rejection' involving interferon-stimulated genes (ISGs) and innate immune effector functions (IEF) underlies diverse immune-mediated tissue destruction processes (allograft rejection, cancer rejection, autoimmunity, infection)
-
Full-text index only
Of brain and bone: the unusual case of Dr. A.
PMID 20183548 · PMC2997763 · Neurocase · 2009 · 7 claims · 8 setups
Dr. A's EXT2 mutation may play a role in the pattern of neurodegeneration seen in his FTD, given that Ext1-knockout mice show CNS defects including loss of olfactory bulbs and abnormally small cerebral cortex